Stock Analysis on Net

Amgen Inc. (NASDAQ:AMGN)

$24.99

Current Ratio
since 2005

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Amgen Inc., current ratio, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions


Current Assets
The current assets of the company demonstrate a general upward trend from 2005 through 2017, rising from approximately 9,235 million US dollars to nearly 49,476 million US dollars. This represents a significant increase over this 12-year span. However, after peaking around 2017, a decline is observed in the subsequent years, notably dropping to around 18,440 million US dollars in 2019. Following this trough, there is a recovery trend, with values increasing again to approximately 30,332 million US dollars by 2023, though a slight decrease is noted in 2024 to just under 29,030 million US dollars.
Current Liabilities
Current liabilities display a more volatile pattern over the years. Starting at about 3,595 million US dollars in 2005, there is a notable increase especially in 2006, reaching around 7,022 million US dollars. Subsequently, the liabilities fluctuate with some years showing reductions, such as in 2009 and 2011, but with a general uptrend from 2012 onwards. By 2024, current liabilities have increased substantially to over 23,000 million US dollars, indicating growing short-term obligations.
Current Ratio
The current ratio, an indicator of short-term liquidity, shows considerable fluctuation throughout the period. It starts relatively high at 2.57 in 2005, dips to a low of 1.26 by 2024, reflecting a decline in liquidity over the long term. Peaks are observed around 2009 and 2013, where the ratio exceeds 4.0, reflecting strong liquidity conditions in those periods. However, a downward trend is apparent after 2013, with values generally declining below 2.0 after 2015, reaching its lowest point in 2024. This suggests increasingly tighter liquidity and potentially greater challenges in covering short-term liabilities from current assets.
Overall Analysis
The data suggests the company experienced strong growth in its current assets up to 2017, which was followed by a sharp contraction and subsequent partial recovery. Meanwhile, current liabilities have gradually increased in later years, exerting pressure on liquidity. The declining current ratio over the final years signals a weakening short-term financial position, which may warrant management attention to ensure operational flexibility and risk mitigation regarding short-term obligations.

Comparison to Competitors

Amgen Inc., current ratio, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Amgen Inc., current ratio, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)